rs2659869
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003737.4(DCHS1):c.1986+17A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.378 in 1,597,090 control chromosomes in the GnomAD database, including 114,821 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 11552 hom., cov: 32)
Exomes 𝑓: 0.38 ( 103269 hom. )
Consequence
DCHS1
NM_003737.4 intron
NM_003737.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.902
Genes affected
DCHS1 (HGNC:13681): (dachsous cadherin-related 1) This gene is a member of the cadherin superfamily whose members encode calcium-dependent cell-cell adhesion molecules. The encoded protein has a signal peptide, 27 cadherin repeat domains and a unique cytoplasmic region. This particular cadherin family member is expressed in fibroblasts but not in melanocytes or keratinocytes. The cell-cell adhesion of fibroblasts is thought to be necessary for wound healing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 11-6634101-T-A is Benign according to our data. Variant chr11-6634101-T-A is described in ClinVar as [Benign]. Clinvar id is 259137.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-6634101-T-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCHS1 | ENST00000299441.5 | c.1986+17A>T | intron_variant | Intron 3 of 20 | 1 | NM_003737.4 | ENSP00000299441.3 | |||
ENSG00000255410 | ENST00000526633.1 | n.211-831T>A | intron_variant | Intron 2 of 2 | 3 | |||||
ENSG00000255410 | ENST00000656961.1 | n.309+2672T>A | intron_variant | Intron 2 of 2 | ||||||
DCHS1 | ENST00000680123.1 | n.-211A>T | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.388 AC: 58943AN: 151922Hom.: 11534 Cov.: 32
GnomAD3 genomes
AF:
AC:
58943
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.381 AC: 91529AN: 240188Hom.: 17432 AF XY: 0.379 AC XY: 48890AN XY: 129136
GnomAD3 exomes
AF:
AC:
91529
AN:
240188
Hom.:
AF XY:
AC XY:
48890
AN XY:
129136
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.377 AC: 545182AN: 1445048Hom.: 103269 Cov.: 50 AF XY: 0.376 AC XY: 269584AN XY: 716386
GnomAD4 exome
AF:
AC:
545182
AN:
1445048
Hom.:
Cov.:
50
AF XY:
AC XY:
269584
AN XY:
716386
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.388 AC: 59002AN: 152042Hom.: 11552 Cov.: 32 AF XY: 0.386 AC XY: 28714AN XY: 74312
GnomAD4 genome
AF:
AC:
59002
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
28714
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1296
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jul 06, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Van Maldergem syndrome 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at